{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:48:48Z","timestamp":1790344128195,"version":"4.1.0"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["521\/18"],"award-info":[{"award-number":["521\/18"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Virus-induced CNS diseases impose a considerable human health burden worldwide. For many viral CNS infections, neither antiviral drugs nor vaccines are available. In this study, we examined whether the synthesis of glycosphingolipids, major membrane lipid constituents, could be used to establish an antiviral therapeutic target. We found that neuroinvasive Sindbis virus altered the sphingolipid levels early after infection in vitro and increased the levels of gangliosides GA1 and GM1 in the sera of infected mice. The alteration in the sphingolipid levels appears to play a role in neuroinvasive Sindbis virus replication, as treating infected cells with UDP-glucose ceramide glucosyltransferase (UGCG) inhibitors reduced the replication rate. Moreover, the UGCG inhibitor GZ-161 increased the survival rates of Sindbis-infected mice, most likely by reducing the detrimental immune response activated by sphingolipids in the brains of Sindbis virus-infected mice. These findings suggest a role for glycosphingolipids in the host immune response against neuroinvasive Sindbis virus and suggest that UGCG inhibitors should be further examined as antiviral therapeutics for viral infections of the CNS.<\/jats:p>","DOI":"10.1093\/braincomms\/fcad086","type":"journal-article","created":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T17:56:19Z","timestamp":1679766979000},"source":"Crossref","is-referenced-by-count":8,"title":["Antiviral activity of glucosylceramide synthase inhibitors in alphavirus infection of the central nervous system"],"prefix":"10.1093","volume":"5","author":[{"given":"Roy","family":"Avraham","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Israel Institute for Biological Research , 7410001 Ness-Ziona , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Melamed","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Israel Institute for Biological Research , 7410001 Ness-Ziona , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Achdout","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Israel Institute for Biological Research , 7410001 Ness-Ziona , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Erez","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Israel Institute for Biological Research , 7410001 Ness-Ziona , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofir","family":"Israeli","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research , 7410001 Ness-Ziona , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moria","family":"Barlev-Gross","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Israel Institute for Biological Research , 7410001 Ness-Ziona , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7482-7885","authenticated-orcid":false,"given":"Metsada","family":"Pasmanik-Chor","sequence":"additional","affiliation":[{"name":"Bioinformatics Unit, George S. Wise Faculty of Life Science, Tel Aviv University , 6997801 Tel Aviv , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Paran","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Israel Institute for Biological Research , 7410001 Ness-Ziona , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomer","family":"Israely","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Israel Institute for Biological Research , 7410001 Ness-Ziona , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8578-8551","authenticated-orcid":false,"given":"Einat B","family":"Vitner","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Israel Institute for Biological Research , 7410001 Ness-Ziona , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,3,25]]},"reference":[{"issue":"3","key":"2023050805264532200_fcad086-B1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s13311-016-0434-6","article-title":"Alphavirus encephalomyelitis: Mechanisms and approaches to prevention of neuronal damage","volume":"13","author":"Griffin","year":"2016","journal-title":"Neurotherapeutics"},{"issue":"4","key":"2023050805264532200_fcad086-B2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0188-4409(02)00378-8","article-title":"The global emergence\/resurgence of arboviral diseases as public health problems","volume":"33","author":"Gubler","year":"2002","journal-title":"Arch Med Res"},{"issue":"2","key":"2023050805264532200_fcad086-B3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrmicro2950","article-title":"West Nile virus infection and immunity","volume":"11","author":"Suthar","year":"2013","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"2023050805264532200_fcad086-B4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12974-016-0570-2","article-title":"Induction of the type I interferon response in neurological forms of Gaucher disease","volume":"13","author":"Vitner","year":"2016","journal-title":"J Neuroinflammation"},{"key":"2023050805264532200_fcad086-B5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fcell.2019.00324","article-title":"Glycosphingolipids and infection. Potential new therapeutic avenues. Review","volume":"7","author":"Aerts","year":"2019","journal-title":"Front Cell Dev Biol"},{"issue":"22","key":"2023050805264532200_fcad086-B6","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1002\/1873-3468.13980","article-title":"The role of brain innate immune response in lysosomal storage disorders: Fundamental process or evolutionary side effect","volume":"594","author":"Vitner","year":"2020","journal-title":"FEBS Lett"},{"issue":"2","key":"2023050805264532200_fcad086-B7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228735","article-title":"Glucosylceramide synthase maintains influenza virus entry and infection","volume":"15","author":"Drews","year":"2020","journal-title":"PLoS One"},{"key":"2023050805264532200_fcad086-B8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100470","article-title":"Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus","volume":"296","author":"Vitner","year":"2021","journal-title":"J Biol Chem"},{"issue":"1","key":"2023050805264532200_fcad086-B9","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202101168","article-title":"Elevation in sphingolipid upon SARS-CoV-2 infection: Possible implications for COVID-19 pathology","volume":"5","author":"Vitner","year":"2022","journal-title":"Life Sci Alliance"},{"issue":"12","key":"2023050805264532200_fcad086-B10","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/AAC.01554-12","article-title":"Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo","volume":"56","author":"Miller","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2023050805264532200_fcad086-B11","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1073\/pnas.94.5.1822","article-title":"Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: Evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion","volume":"94","author":"Mehta","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2023050805264532200_fcad086-B12","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1053\/jhep.2001.25103","article-title":"Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: Therapeutic implications","volume":"33","author":"Mehta","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"2023050805264532200_fcad086-B13","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1128\/AAC.01319-10","article-title":"Inhibitors of endoplasmic reticulum alpha-glucosidases potently suppress hepatitis C virus virion assembly and release","volume":"55","author":"Qu","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"15","key":"2023050805264532200_fcad086-B14","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1097\/QAD.0b013e32830efd96","article-title":"N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery","volume":"22","author":"Pollock","year":"2008","journal-title":"AIDS"},{"issue":"10","key":"2023050805264532200_fcad086-B15","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1128\/jvi.70.10.7153-7160.1996","article-title":"N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure","volume":"70","author":"Fischer","year":"1996","journal-title":"J Virol"},{"issue":"1","key":"2023050805264532200_fcad086-B16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/JVI.74.1.564-572.2000","article-title":"Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum","volume":"74","author":"Courageot","year":"2000","journal-title":"J Virol"},{"issue":"13","key":"2023050805264532200_fcad086-B17","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1021\/jm300171v","article-title":"Design, synthesis, and biological evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infection","volume":"55","author":"Yu","year":"2012","journal-title":"J Med Chem"},{"issue":"1","key":"2023050805264532200_fcad086-B18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/jac\/dku349","article-title":"Strain-specific antiviral activity of iminosugars against human influenza A viruses","volume":"70","author":"Hussain","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"2023050805264532200_fcad086-B19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004524","article-title":"Iminosugars inhibit dengue virus production via inhibition of ER alpha-glucosidases-not glycolipid processing enzymes","volume":"10","author":"Sayce","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"2023050805264532200_fcad086-B20","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","article-title":"N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis","volume":"269","author":"Platt","year":"1994","journal-title":"J Biol Chem"},{"key":"2023050805264532200_fcad086-B21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-3-7091-1511-4_20","article-title":"Neuronal forms of Gaucher disease","volume":"216","author":"Vitner","year":"2013","journal-title":"Handb Exp Pharmacol"},{"issue":"3-4","key":"2023050805264532200_fcad086-B22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF01317186","article-title":"A novel variant of sindbis virus is both neurovirulent and neuroinvasive in adult mice","volume":"122","author":"Lustig","year":"1992","journal-title":"Arch Virol"},{"issue":"4","key":"2023050805264532200_fcad086-B23","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1128\/jvi.71.4.2636-2646.1997","article-title":"Genetic determinants of sindbis virus neuroinvasiveness","volume":"71","author":"Dubuisson","year":"1997","journal-title":"J Virol"},{"issue":"6","key":"2023050805264532200_fcad086-B24","doi-asserted-by":"crossref","first-page":"e01517-17","DOI":"10.1128\/JVI.01517-17","article-title":"Interleukin-10 modulation of virus clearance and disease in mice with alphaviral encephalomyelitis","volume":"92","author":"Martin","year":"2018","journal-title":"J Virol"},{"issue":"16","key":"2023050805264532200_fcad086-B25","doi-asserted-by":"crossref","first-page":"8280","DOI":"10.1128\/JVI.00173-15","article-title":"Distinct immune responses in resistant and susceptible strains of mice during neurovirulent alphavirus encephalomyelitis","volume":"89","author":"Kulcsar","year":"2015","journal-title":"J Virol"},{"issue":"5","key":"2023050805264532200_fcad086-B26","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/db06-0719","article-title":"Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes","volume":"56","author":"Zhao","year":"2007","journal-title":"Diabetes"},{"key":"2023050805264532200_fcad086-B27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2119\/molmed.2015.00088","article-title":"Efficacy of enzyme and substrate reduction therapy with a novel antagonist of glucosylceramide synthase for Fabry disease","volume":"21","author":"Ashe","year":"2015","journal-title":"Mol Med"},{"issue":"6","key":"2023050805264532200_fcad086-B28","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/mt.2016.53","article-title":"CNS-accessible inhibitor of glucosylceramide synthase for substrate reduction therapy of neuronopathic Gaucher disease","volume":"24","author":"Marshall","year":"2016","journal-title":"Mol Ther"},{"issue":"8","key":"2023050805264532200_fcad086-B29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043310","article-title":"Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease","volume":"7","author":"Cabrera-Salazar","year":"2012","journal-title":"PLoS One"},{"issue":"22","key":"2023050805264532200_fcad086-B30","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1128\/JVI.76.22.11254-11264.2002","article-title":"Roles of nonstructural protein nsP2 and alpha\/beta interferons in determining the outcome of sindbis virus infection","volume":"76","author":"Frolova","year":"2002","journal-title":"J Virol"},{"issue":"1","key":"2023050805264532200_fcad086-B31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12859-019-2728-2","article-title":"UTAP: User-friendly transcriptome analysis pipeline","volume":"20","author":"Kohen","year":"2019","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"2023050805264532200_fcad086-B32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kramer","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"2023050805264532200_fcad086-B33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"issue":"D1","key":"2023050805264532200_fcad086-B34","doi-asserted-by":"crossref","first-page":"D419","DOI":"10.1093\/nar\/gky1038","article-title":"PANTHER Version 14: More genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools","volume":"47","author":"Mi","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2023050805264532200_fcad086-B35","doi-asserted-by":"crossref","first-page":"D330","DOI":"10.1093\/nar\/gky1055","article-title":"The gene ontology resource: 20 years and still going strong","volume":"47","author":"The Gene Ontology Consortium","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2023050805264532200_fcad086-B36","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: Customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2023050805264532200_fcad086-B37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s40478-020-01020-6","article-title":"Innate immune response in neuronopathic forms of Gaucher disease confers resistance against viral-induced encephalitis","volume":"8","author":"Melamed","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"2023050805264532200_fcad086-B38","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1128\/JVI.77.9.5333-5338.2003","article-title":"Luciferase imaging of a neurotropic viral infection in intact animals","volume":"77","author":"Cook","year":"2003","journal-title":"J Virol"},{"key":"2023050805264532200_fcad086-B39","volume-title":"Fields virology","author":"Griffin","year":"2013","edition":"6th edn"},{"issue":"8","key":"2023050805264532200_fcad086-B40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/1753425918800200","article-title":"When and how NK cell-induced programmed cell death benefits immunological protection against intracellular pathogen infection","volume":"24","author":"Beliz\u00e1rio","year":"2018","journal-title":"Innate Immun"},{"issue":"11","key":"2023050805264532200_fcad086-B41","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.3390\/ijms21113909","article-title":"License to kill: When iNKT cells are granted the use of lethal cytotoxicity","volume":"21","author":"D\u00edaz-Basabe","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2023050805264532200_fcad086-B42","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004721","article-title":"Lipid-mediated endocytosis","volume":"3","author":"Ewers","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"2023050805264532200_fcad086-B43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ymgme.2007.04.001","article-title":"A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease","volume":"91","author":"McEachern","year":"2007","journal-title":"Mol Genet Metabol"},{"issue":"7503","key":"2023050805264532200_fcad086-B44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"key":"2023050805264532200_fcad086-B45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.abb.2015.02.007","article-title":"Regulatory function of glycosphingolipids in the inflammation and degeneration","volume":"571","author":"Furukawa","year":"2015","journal-title":"Arch Biochem Biophys"},{"key":"2023050805264532200_fcad086-B46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-030-21735-8_15","article-title":"Roles of ceramides and other sphingolipids in immune cell function and inflammation","volume":"1161","author":"Albeituni","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"2023050805264532200_fcad086-B47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol cell Biol"},{"issue":"10","key":"2023050805264532200_fcad086-B48","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm.3681","article-title":"Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation","volume":"20","author":"Mayo","year":"2014","journal-title":"Nat Med"},{"issue":"10","key":"2023050805264532200_fcad086-B49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164377","article-title":"A lipidomics approach in the characterization of zika-infected mosquito cells: Potential targets for breaking the transmission cycle","volume":"11","author":"Melo","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"2023050805264532200_fcad086-B50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.celrep.2016.05.070","article-title":"Cytomegalovirus restructures lipid rafts via a US28\/CDC42-mediated pathway, enhancing cholesterol efflux from host cells","volume":"16","author":"Low","year":"2016","journal-title":"Cell Rep"},{"issue":"7","key":"2023050805264532200_fcad086-B51","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1194\/jlr.M049148","article-title":"Lipidomics identifies a requirement for peroxisomal function during influenza virus replication","volume":"55","author":"Tanner","year":"2014","journal-title":"J Lipid Res"},{"issue":"16","key":"2023050805264532200_fcad086-B52","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1128\/JVI.00870-08","article-title":"Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins","volume":"82","author":"Achdout","year":"2008","journal-title":"J Virol"},{"issue":"23","key":"2023050805264532200_fcad086-B53","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1002\/1873-3468.13275","article-title":"The regulatory roles of glycosphingolipid-enriched lipid rafts in immune systems","volume":"592","author":"Nakayama","year":"2018","journal-title":"FEBS Lett"},{"issue":"6","key":"2023050805264532200_fcad086-B54","doi-asserted-by":"crossref","first-page":"E336","DOI":"10.1073\/pnas.1114965109","article-title":"CD4 And CD8 T cells require different membrane gangliosides for activation","volume":"109","author":"Nagafuku","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2023050805264532200_fcad086-B55","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nri726","article-title":"Lipid rafts and B-cell activation","volume":"2","author":"Pierce","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"2023050805264532200_fcad086-B56","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3389\/fimmu.2017.00848","article-title":"Glucosylceramide synthase is involved in development of invariant natural killer T cells","volume":"8","author":"Popovic","year":"2017","journal-title":"Front Immunol"},{"issue":"12","key":"2023050805264532200_fcad086-B57","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/ni.2143","article-title":"Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals","volume":"12","author":"Brennan","year":"2011","journal-title":"Nat Immunol"},{"issue":"1","key":"2023050805264532200_fcad086-B58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/gut.2006.095497","article-title":"\u03b2-Glucosylceramide: A novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders","volume":"56","author":"Zigmond","year":"2007","journal-title":"Gut"},{"issue":"6","key":"2023050805264532200_fcad086-B59","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11745-012-3666-1","article-title":"Beta-glucosylceramide administration (i.p.) activates natural killer T cells in vivo and prevents tumor metastasis in mice","volume":"47","author":"Inafuku","year":"2012","journal-title":"Lipids"},{"issue":"3","key":"2023050805264532200_fcad086-B60","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00280-008-0896-2","article-title":"Tumor specific cytotoxicity of beta-glucosylceramide: Structure-cytotoxicity relationship and anti-tumor activity in vivo","volume":"64","author":"Oku","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"2023050805264532200_fcad086-B61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000169","article-title":"TLR9-mediated dendritic cell activation uncovers mammalian ganglioside species with specific ceramide backbones that activate invariant natural killer T cells","volume":"17","author":"Paget","year":"2019","journal-title":"PLoS Biol"},{"issue":"8","key":"2023050805264532200_fcad086-B62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002838","article-title":"Invariant NKT cells: Regulation and function during viral infection","volume":"8","author":"Juno","year":"2012","journal-title":"PLoS Pathog"},{"issue":"12","key":"2023050805264532200_fcad086-B63","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1002\/eji.200939800","article-title":"NKT Cells: Friend or foe during viral infections?","volume":"39","author":"Diana","year":"2009","journal-title":"Eur J Immunol."},{"issue":"3","key":"2023050805264532200_fcad086-B64","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cell.2017.11.036","article-title":"Initiation of antiviral B cell immunity relies on innate signals from spatially positioned NKT cells","volume":"172","author":"Gaya","year":"2018","journal-title":"Cell"},{"key":"2023050805264532200_fcad086-B65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.coi.2014.01.007","article-title":"Invariant NKT cells provide innate and adaptive help for B cells","volume":"28","author":"Vomhof-DeKrey","year":"2014","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"2023050805264532200_fcad086-B66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087717","article-title":"Invariant NKT cells regulate the CD8 T cell response during Theiler's virus infection","volume":"9","author":"Mars","year":"2014","journal-title":"PLoS One"},{"key":"2023050805264532200_fcad086-B67","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jneuroim.2016.04.010","article-title":"T cell-derived interleukin-10 is an important regulator of the Th17 response during lethal alphavirus encephalomyelitis","volume":"295-296","author":"Kulcsar","year":"2016","journal-title":"J Neuroimmunol"},{"issue":"45","key":"2023050805264532200_fcad086-B68","doi-asserted-by":"crossref","first-page":"16053","DOI":"10.1073\/pnas.1418966111","article-title":"Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis","volume":"111","author":"Kulcsar","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2023050805264532200_fcad086-B69","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0165-5728(02)00108-X","article-title":"Contribution of T cells to mortality in neurovirulent sindbis virus encephalomyelitis","volume":"127","author":"Rowell","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2023050805264532200_fcad086-B70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrd703","article-title":"Strategies in the design of antiviral drugs","volume":"1","author":"De Clercq","year":"2002","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"2023050805264532200_fcad086-B71","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrmicro975","article-title":"Antivirals and antiviral strategies","volume":"2","author":"Clercq","year":"2004","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"2023050805264532200_fcad086-B72","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2013.03.020","article-title":"Curing a viral infection by targeting the host: The example of cyclophilin inhibitors","volume":"99","author":"Lin","year":"2013","journal-title":"Antiviral Res"},{"issue":"2","key":"2023050805264532200_fcad086-B73","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12325-016-0474-7","article-title":"Modulation of neuroinflammation in the central nervous system: Role of chemokines and sphingolipids.","volume":"34","author":"Gualtierotti","year":"2017","journal-title":"Adv Ther"},{"issue":"7503","key":"2023050805264532200_fcad086-B74","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature13476","article-title":"Sphingolipid lysosomal storage disorders","volume":"510","author":"Platt","year":"2014","journal-title":"Nature"},{"issue":"7","key":"2023050805264532200_fcad086-B75","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3390\/ijms17071065","article-title":"Less is more: Substrate reduction therapy for lysosomal storage disorders","volume":"17","author":"Coutinho","year":"2016","journal-title":"Int J Mol Sci"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcad086\/49633000\/fcad086.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/5\/3\/fcad086\/50234949\/fcad086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/5\/3\/fcad086\/50234949\/fcad086.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T05:27:27Z","timestamp":1683523647000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcad086\/7086080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcad086","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023]]},"published":{"date-parts":[[2023]]},"article-number":"fcad086"}}